Psychiatry Education Forum
  • Academy Chapters
  • Psychiatry Studio
  • Blog
  • Pricing
  • Contact Us
    • Reviews
    Sign in
    Close search

    Tag: antipsychotics

    Which Antipsychotics have Highest Pneumonia Risk?

    Antipsychotic medications are critical in managing schizophrenia and other related disorders, but they come with various side effects, one of which is the increased risk…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh October 13, 2024

    Is Lurasidone Safe with Weight Gain Risk?

    While antipsychotic medications have significantly improved the lives of individuals with severe mental health disorders, the potential for weight gain should not be overlooked. Antipsychotic…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh February 13, 2024

    Geriatric Psychiatry Update: ChEIs for Psychotic Symptoms

    According to this recent meta-analysis published in JAMA Neurology on June 26, 2023: Cholinesterase Inhibitors treatment improves psychotic symptoms in patients with Alzheimer’s disease &…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh August 5, 2023

    Antipsychotics & Weight Gain: Update 2023

    PSYCHIATRY EDUCATION FORUM ACADEMY’S ANTIPSYCHOTICS & WEIGHT GAIN: UPDATE 2023 Dear PEFA Academy Members. We are excited to announce the release of our next educational…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh April 24, 2023

    Antipsychotics Induced Nocturnal Enuresis

    Nocturnal Enuresis, also known as bedwetting, is one of the underrecognized side effects from atypical antipsychotics. A comparative cohort study found that approximately one in…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh February 18, 2023

    Journal Club 14: Dose-Response Meta-Analysis of Antipsychotics for Acute Schizophrenia

    Psychiatry Education Forum Academy is excited to release our next journal club discussion today. This journal club will focus on this clinically relevant topic of…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh February 19, 2022

    Antipsychotic of choice for “Schizo-Obsessive” Disorder?

    BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 There is growing evidence that patients with comorbid obsessive-compulsive disorder (OCD) and schizophrenia may represent a…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh November 26, 2021

    Antipsychotics & risk of Hypersexual or Paraphilic Behaviors

    We know that dopamine agonism can result in hypersexual or paraphilic behaviors but interestingly, case reports for second-generation antipsychotics association with increase in hypersexual behavior…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh August 11, 2021

    [Journal Club #10]: Antipsychotics & Weight Gain

    Today we posted our 10th journal club in PEFA Journal Club’s discussion series, discussing the risk of weight gain with antipsychotics: Journal Club #10: Almost…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 21, 2021

    [Journal Club #6 + #7]: Two New Schizophrenia Medications with Novel Mechanism of Action

    Today we posted the sixth and seventh journal club in PEFA Journal Club’s discussion series, discussing the following two newer antipsychotics for schizophrenia treatment: (A)…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 18, 2021

    [Journal Club #5 + Coffee Club]: Comparing 32 Oral Antipsychotics for Acute Schizophrenia Management.

    Today we posted the following fifth journal club in PEFA Journal Club’s discussion series and discussion with a expert in our Coffee Club’s discussion section:…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 17, 2021

    Lumateperone: Mechanism of Action?

    Lumateperone is the most recently approved FDA-approved medication for the treatment of schizophrenia. Watch the following short video discussion from our journal club regarding the…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh April 25, 2021

    PEF Clinical Fact: Antipsychotic of Choice in COVID & Pneumonia

    INTERESTED IN LEARNING MORE? JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP This educational activity is dedicated to the essential and must-know clinical facts regarding the interaction…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh January 27, 2021

    Join Academy Membership

    CME Academy

    Most Recent Posts

    • Before You Diagnose Hyperprolactinemia — Confirm It Correctly! October 11, 2025
    • Comparing Aripiprazole vs rTMS Augmentation vs SNRI Switch in TRD September 27, 2025
    • ADHD Treatment During Pregnancy: What the Latest Evidence Means for Mothers and Clinicians September 18, 2025
    • ANK3 Biomarker Unlocks Liafensine’s Potential in Treatment-Resistant Depression September 13, 2025
    • Propranolol + Sertraline: New Evidence in Treating Panic Disorder in Women September 6, 2025
    • Weekly Oral Risperidone (LYN‑005): Breakthrough in Schizophrenia Treatment? September 1, 2025
    • EEG Biomarkers to Predict Antidepressant Response: Emerging Evidence August 28, 2025
    • RE104 Shows Rapid & Durable Relief in Postpartum Depression August 25, 2025
    • Can Creatine Supplementation Help Depression? August 22, 2025
    • Naltrexone-Bupropion Shows Promise for Methamphetamine Use Disorder with Depression August 16, 2025
    • Pramipexole for TRD: Promising 48-Week Results August 9, 2025
    • Esketamine Monotherapy Works—New Trial Validates FDA Approval August 5, 2025
    • Centanafadine: Non-Stimulant Option for ADHD That Works in Just One Week? August 1, 2025

    Please note that this website is for educational purposes only and do refer to sources cited at the end of each topics for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons or property from any use of any ideas, information, or instruction in this website.

    Psychiatry Education Forum
    © 2025 - Psychiatry Education Forum   DISCLAIMER: Please note that this website is for educational purposes only and do refer to sources cited at the end of each topic for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons, or property from any use of any ideas, information, or instruction in this website.

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • Mention this member in posts
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .